Mesoblast Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	65.38	17.2	5.9	7.5	10.21	7.43
Revenue Growth	280.18%	191.39%	-21.32%	-26.54%	37.35%	-76.88%
Cost of Revenue	12.73	5.13	-	-	-	-
Gross Profit	52.65	12.07	5.9	7.5	10.21	7.43
Selling, General & Admin	49.84	39.31	24.98	27.48	57.97	63.59
Research & Development	75.88	34.81	39.72	52.82	32.82	53.01
Other Operating Expenses	-6.52	16.8	6.34	-10.82	-6.27	-20.25
Total Operating Expenses	119.2	90.91	71.04	69.48	84.51	96.35
Operating Income	-66.55	-78.84	-65.14	-61.98	-74.3	-88.92
Interest Expense	-27.25	-22.97	-23.01	-20.12	-17.29	-10.71
Total Non-Operating Income (Expense)	-27.25	-22.97	-23.01	-20.12	-17.29	-10.71
Pretax Income	-93.81	-101.81	-88.15	-82.1	-91.59	-99.63
Provision for Income Taxes	0.56	0.33	-0.19	-0.21	-0.24	-0.82
Net Income	-94.37	-102.14	-87.96	-81.89	-91.35	-98.81
Net Income to Common	-94.37	-102.14	-87.96	-81.89	-91.35	-98.81
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	128	121	99	78	68	61
Shares Outstanding (Diluted)	128	121	99	78	68	61
Shares Change	6.20%	22.41%	26.87%	13.89%	12.86%	14.42%
EPS (Basic)	-0.74	-0.85	-0.89	-1.05	-1.34	-1.63
EPS (Diluted)	-0.74	-0.85	-0.89	-1.05	-1.34	-1.63
EPS Growth	-	-	-	-	-	-
Free Cash Flow	-43.52	-50.63	-48.73	-63.53	-65.94	-102.4
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-0.34	-0.42	-0.49	-0.82	-0.97	-1.69
Gross Margin	80.52%	70.17%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-101.79%	-458.45%	-1103.66%	-826.28%	-727.63%	-1196.07%
Profit Margin	-144.33%	-593.92%	-1490.27%	-1091.71%	-894.59%	-1329.18%
FCF Margin	-66.57%	-294.42%	-825.63%	-846.99%	-645.76%	-1377.40%
EBITDA	-66.55	-72.44	-60.47	-57.87	-69.92	-84.65
EBITDA Margin	-101.79%	-421.23%	-1024.60%	-771.52%	-684.73%	-1138.71%
EBIT	-66.55	-78.84	-65.14	-61.98	-74.3	-88.92
EBIT Margin	-101.79%	-458.45%	-1103.66%	-826.28%	-727.63%	-1196.07%
Effective Tax Rate	-0.60%	-0.32%	0.22%	0.26%	0.26%	0.82%

SEC Filings: 10-K · 10-Q